Danimer Scientific Independent Director Acquires 29% More Stock
Danimer Scientific Independent Director Acquires 29% More Stock
Even if it's not a huge purchase, we think it was good to see that Richard Hendrix, the Independent Director of Danimer Scientific, Inc. (NYSE:DNMR) recently shelled out US$93k to buy stock, at US$0.93 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 29%.
即使這不是一筆巨額收購,我們也認爲很高興看到丹尼默科學公司(紐約證券交易所代碼:DNMR)的獨立董事理查德·亨德里克斯最近以每股0.93美元的價格出資9.3萬美元購買股票。儘管我們對如此規模的收購猶豫不決,但我們確實注意到他們的持股量穩步增長了29%。
View our latest analysis for Danimer Scientific
查看我們對 Danimer Scientific 的最新分析
The Last 12 Months Of Insider Transactions At Danimer Scientific
丹尼默科學公司過去 12 個月的內幕交易
In fact, the recent purchase by Richard Hendrix was the biggest purchase of Danimer Scientific shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price (US$1.09), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
實際上,根據我們的記錄,理查德·亨德里克斯最近的收購是內部人士在過去十二個月中對丹尼默科學股票的最大一筆收購。儘管此次收購的價格明顯低於近期價格(1.09美元),但我們仍然認爲內幕買盤是積極的。由於股票是以較低的價格購買的,因此這次特別的買入並不能告訴我們內部人士對當前股價的看法。
The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
下圖顯示了去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231201/0-aaab03d7e40bae988c8fff4a9ea75f24-0-fff55e850cf9b327307dcf92e8ef675b.png/big)
Danimer Scientific is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Danimer Scientific並不是業內人士唯一買入的股票。對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。
Insider Ownership
內部所有權
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Danimer Scientific insiders own 12% of the company, worth about US$13m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
對於普通股股東來說,值得檢查一下公司內部人士持有多少股票。我認爲,如果內部人士擁有該公司的大量股份,那將是一個好兆頭。看來丹尼默科學內部人士擁有該公司12%的股份,價值約1300萬美元。儘管這是內部人所有權強勁但並不突出的水平,但這足以表明管理層與小股東之間有一定的一致性。
What Might The Insider Transactions At Danimer Scientific Tell Us?
Danimer Scientific的內幕交易會告訴我們什麼?
The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Insiders likely see value in Danimer Scientific shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Danimer Scientific. At Simply Wall St, we've found that Danimer Scientific has 3 warning signs (1 shouldn't be ignored!) that deserve your attention before going any further with your analysis.
最近的內幕收購令人振奮。對去年交易的分析也給了我們信心。但是,我們注意到該公司在過去十二個月中沒有盈利,這使我們持謹慎態度。鑑於這些交易(以及該公司顯著的內部所有權),業內人士可能會看到丹尼默科學股票的價值。除了了解正在進行的內幕交易外,確定Danimer Scientific面臨的風險也是有益的。在 Simply Wall St,我們發現 Danimer Scientific 有 3 個警告標誌(1 個不容忽視!)在進一步分析之前,這值得你關注。
Of course Danimer Scientific may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,丹尼默科學可能不是最值得買入的股票。因此,您可能希望看到這些免費的高質量公司集。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。